About Embecta
Embecta is a company based in Parsippany (United States) founded in 2022.. The company has 2,100 employees as of September 30, 2024. Embecta has completed 1 acquisition, including Owen Mumford. Embecta offers products and services including Pen Needles and Insulin Syringes.
- Headquarter Parsippany, United States
- Employees 2100 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Embecta Corp.
-
Annual Revenue
$1.08 B-3.8as on Sep 30, 2025
-
Net Profit
$95.4 M21.84as on Sep 30, 2025
-
EBITDA
$380.4 M75.54as on Sep 30, 2025
-
Latest Funding Round
-
Investors
-
Employee Count
2100
as on Sep 30, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Embecta
Embecta is a publicly listed company on the NASDAQ with ticker symbol EMBC in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Embecta
Embecta offers a comprehensive portfolio of products and services, including Pen Needles and Insulin Syringes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Pen needles are manufactured for use in insulin delivery to aid diabetes management.
Insulin syringes are supplied for administering insulin as part of diabetes care practices.
Unlock access to complete
Leadership Team
15 people
Human Resources and Administration
14 people
Finance and Accounting
13 people
Legal and Compliance
7 people
Sales and Marketing
6 people
Software Development Team
6 people
Operations Team
2 people
Regional Team
2 people
Unlock access to complete
Funding Insights of Embecta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Embecta
Embecta has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Owen Mumford. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Disposables for drug delivery and capillary blood sampling are manufactured.
|
1952 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Embecta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Embecta Comparisons
Competitors of Embecta
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Embecta
Frequently Asked Questions about Embecta
When was Embecta founded?
Embecta was founded in 2022.
Where is Embecta located?
Embecta is headquartered in Parsippany, United States. It is registered at Parsippany, New Jersey, United States.
Who is the current CEO of Embecta?
Devdatt Kurdikar is the current CEO of Embecta.
How many employees does Embecta have?
As of Sep 30, 2024, the latest employee count at Embecta is 2,100.
What is the annual revenue of Embecta?
Annual revenue of Embecta is $1.08B as on Sep 30, 2025.
What does Embecta do?
Embecta was founded in 2022 and is headquartered in Parsippany, United States. Operations are centered in the healthcare sector, with a focus on diabetes management. Insulin delivery products such as pen needles and syringes are developed and supplied to support daily care needs. Efforts are directed toward enhancing injection experiences through innovation. Educational resources and guidance on proper injection techniques are also made available to users.
What products or services does Embecta offer?
Embecta offers Pen Needles and Insulin Syringes.
Is Embecta publicly traded?
Yes, Embecta is publicly traded on NASDAQ under the ticker symbol EMBC.
How many acquisitions has Embecta made?
Embecta has made 1 acquisition, including Owen Mumford.
What is Embecta's ticker symbol?
The ticker symbol of Embecta is EMBC on NASDAQ.